To evaluate short-term and long-term safety and efficacy of intravenous cidofovir (HPMPC) for
treatment of small peripheral cytomegalovirus (CMV) retinitis lesions. To provide data on the
relative safety and efficacy of 2 doses of HPMPC as maintenance regimens.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)